Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EX1C
|
|||
| Former ID |
DIB002066
|
|||
| Drug Name |
RASV-Sp
|
|||
| Synonyms |
Recombinant attenuated Salmonella Typhi vaccine vectors expressing the Streptococcus pneumoniae surface protein (PspA) alpha-helical domain fused to B-lactamase (oral, Streptococcus pneumoniae infection), Arizona State University
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Streptococcus infection [ICD-11: 1B53; ICD-10: G00.1, G00.2] | Phase 1 | [1] | |
| Company |
Arizona State University
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Staphylococcus Beta-lactamase (Stap-coc blaZ) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rapid, Sensitive Recovery of Recombinant Attenuated Salmonella enterica Serovar Typhi Vaccine Strains from Human Blood. Clin Vaccine Immunol. 2013 September; 20(9): 1473-1478. | |||
| REF 2 | WO patent application no. 2010,0456,20, Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.